7 Mar 2018 07:00
London, 7 March 2018
ANNUAL REPORT 2017
Georgia Healthcare Group PLC ("GHG" or the "Group") (LSE:GHG) has today published its Annual Report and Accounts for the financial year ended 31 December 2017 (the "Annual Report 2017").
A copy of the Annual Report 2017 has been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM. The Annual Report 2017 is also available on the Group's website at ghg.com.ge.
Details of the Company's Annual General Meeting, expected to be held in April, will be sent to shareholders separately in the coming weeks.
Name of authorised official of issuer responsible for making notification:
Ketevan Kalandarishvili, Head of Investor Relations
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a UK incorporated holding company of the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 37 hospitals and 12 polyclinic clusters (consisting of 16 polyclinics and 24 express outpatient clinics), as at 31 December 2017. GHG is the single largest market participant, accounting for 24.5% of total hospital bed capacity in the country, as of 31 December 2017. From January 2017, GHG become the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 30% market share by revenue. GHG is the second largest provider of medical insurance in Georgia with a 29.0% market share based on net insurance premiums earned and approximately 155,000 insurance customers as at January 2018. GHG employed a total of c.15,100 people as at 31 December 2017, including c.3,500 physicians.
For further information, please visit ghg.com.ge or contact:
Nikoloz Gamkrelidze | Irakli Gogia | Ketevan Kalandarishvili |
CEO | CFO | Head of Investor Relations |
+995 322 550505 (5077) | +995 322 550505 (5088) | +995 322 550505 (5079) |
ngamkrelidze@ghg.com.ge | irakligogia@ghg.com.ge | ir@ghg.com.ge |
This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities